EMA/INS/GMP/20217/2026
Version milestone
Publication Date
19 Jan 2026
guidelines.detail.timeline.expected_date
01 Dec 2026
This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II.
Chronological release history
Version milestone
Publication Date
19 Jan 2026
guidelines.detail.timeline.expected_date
01 Dec 2026
Version milestone
Publication Date
30 Mar 2015
Effective Date
01 Oct 2015
We use cookies to improve your experience, analyse website usage, and show you relevant information. By accepting all cookies, you help us improve the website. View our privacy statement.
Necessary
Always active. Required for the website to function properly.
Statistics
Helps us improve the website through anonymous statistics.
Marketing
For third-party marketing and tracking cookies.